-
An oral direct thrombin inhibitor, dabigatran, prevents ischemic strokes in patients with atrial fibrillation, with fewer hemorrhagic strokes as compared to warfarin.
-
In a delayed-start trial of rasagiline in early Parkinson's disease, 1 mg rasagiline daily met all three predetermined endpoints consistent with disease modification. However, a dose of 2 mg daily did not meet all endpoints, complicating interpretation.
-
Depression and pregnancy, new vaccine recommendations from the CDC, cortico-steroids and/or antivirals for Bell's palsy, rasagiline and Parkinson's disease, and FDA Actions.
-
-
Review of available literature suggests that combination therapy of Bell's palsy with both steroids and anti-virals results in the best outcome.
-
Recent breakthroughs in genetic research will bring us closer to being able to diagnose an individual's risk of developing late-onset sporadic Alzheimer's disease.
-
Muscle biopsy still remains an important test for determining correct diagnosis and treatment of patients with suspected muscle disease.
-
-
-
Depression and pregnancy, new vaccine recommendations from the CDC, cortico-steroids and/or antivirals for Bell's palsy, rasagiline and Parkinson's disease, and FDA Actions.